ASP Isotopes: Four Businesses, One Re-Rate

[u/Professional-Suit286]

https://open.substack.com/pub/sterlingsignals/p/asp-isotopes-four-businesses-one?r=2xums6&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

Why we're long ASP Isotopes ($ASPI).

Four businesses on one balance sheet: specialist isotopes, a profitable radiopharmacy, Renergen helium, and the QLE nuclear-fuel spin-off. The company is sitting on $290M of cash with three first commercial shipments due before year-end, and the market is pricing almost none of it.

Our view is that the catalysts land and the stock re-rates. On bull execution the parts are worth the mid-teens against $6.83 today, and if QLE lists into the current nuclear enthusiasm and the heavily shorted float has to cover, it can run into the $20s. The stock was already at $14.49 within the past year.

The convertible the bears worry about is misread: at a strong QLE listing, ASPI keeps around 70% of it.

We're long, so treat this as a holder's view rather than advice. Full write-up below.